Chondroitinase ABC (chABC) has evolved as a promising therapeutic for the degradation of inhibitory chondroitin sulfate proteoglycans (CSPGs) after injury to the central nervous system (CNS). The enzymatic breakdown of CSPGs by administered chABC reinstated plasticity as well as axon regeneration; leading to improved CNS recovery. Thus in an effort to develop and evaluate treatments of 10 CNS injury utilising chABC the accurate detection of levels of CSPGs and more importantly activity of chABC activity is of paramount importance. Here we present a spectrophotometric assay suitable for accurately and quantitatively measuring chABC activity, based on the use of 4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate (WST-1). This novel WST-1 based assay was compared to two other assays: measurement of alkene generation at 232 nm and a 1,9 dimethyl methylene 15 blue (DMMB) assay which have been used previously for the detection of chABC activity and CSPGs respectively. Comparison of these assays demonstrated that the WST-1 assay was quantitative, efficient, cheap and easy to perform and overall was superior in the detection of chABC activity at all concentrations when compared to the other methods tested.
Introduction
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Chondroitin sulfate proteoglycans (CSPGs) are a diverse group of extracellular compounds consisting of a core protein and one or more covalently attached sulfated glycosaminoglycan (GAG) side chains. 1 CSPGs play critical roles in a range of biological processes and diseases, providing a cellular framework to direct 25 and at times inhibit cell growth and tissue formation within the extracellular matrix via activation of cell signalling pathways. 2, 3 Within the central nervous system (CNS) CSPGs play an important role in axon guidance during development as well as in the formation and maturation of perineuronal nets (PNNs). Formation of PNNs has been well characterised to signal the maturation of synaptic connections and in turn the closing of the CNS's plastic phase. [3] [4] [5] Following injury to the CNS a range of biochemical changes occur, including a sharp rise in the levels of CSPGs associated with the formation of the glial scar at the 35 primary injury. 4 It has been shown that the presence of CSPGs at the site of injury results in an environment that is inhibitory to axon regeneration and axonal plasticity, two important factors required for restoration of function post-CNS injury. 1, 4 Chondroitinase ABC (chABC), has been used to successfully 40 degrade CSPGs and PNN structures at the site of a CNS injury both in vitro and in vivo, which in turn resulted in axon regeneration and more importantly the reintroduction of plasticity at the injury site. 1, 4, 6 Despite this proof-of-concept demonstration of the use of chABC in treating CNS injury, several limitations 45 have been reported. . chABC cleavage of chondroitin sulfate A to produce the reducing disaccharide (detected by WST-1) and the 4,5-unsaturated disaccharide product (detected by measuring the absorbance at 232 nm). DMMB will bind to large intact proteoglycans.
The most notable of these is that the enzyme is thermally sensitive and almost all of its activity is lost within 3-5 days at 37 °C. 7 In order to develop better methods of delivery of chABC,
given the potential of chABC as a therapeutic intervention, the ability to quantify and accurately assay its activity in model 5 systems is of paramount importance. This is especially important in comparing efficacy of treatments given the broad range in the persistence of enzyme activity seen with commercially purchased chABC batches. 7 The enzyme commonly used in these studies is chABC from 10 Proteus vulgaris. It has broad substrate specificity degrading chondroitin, chondroitin-4-sulfate (also known as chondroitin sulfate A, CS-A), chondroitin-6-sulfate, dermatan sulfate, and hyaluronan by β-elimination of 1,4-hexosaminidic bonds to produce Δ4,5-unsaturated disaccharides and a reducing end further method that has been used for detection of chABC activity involves measuring the formation of the C4-C5 double bond in the product material at 232 nm ( Figure 1 ). Unfortunately, this method also suffers from problems associated with potential interferences at this wavelength and these problems are 40 compounded by the fact that alkenes are relatively weak chromophores. 9 One method that has received some attention for the detection of biological products 17 is the use of tetrazolium salts that produce highly coloured formazan dyes under reducing 45 conditions. The compound of choice, 4-
, is used in cell metabolism kits (Roche), cell viability assays 18 and for measuring anti-inflammatory responses. 19, 20 To date though, the use of this system in assaying for carbohydrate-processing 50 enzyme activity has only received limited attention. 21 The use of WST-1 has advantages in that it is a direct measure of enzyme activity due to its ability to form water-soluble complexes that result in a stable complex suitable for accurate spectrophotometric measurements. Spectrophotometric detection 55 is achieved through direct incubation of the WST-1, which in turn reacts with the newly formed reducing disaccharide found only in the product (Figure 1 ), reducing the WST-1 to WST-1 formazan. 21 To date however a rigorous investigation into the use of WST-1 for measuring chABC activity has not been conducted.
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If this method was amenable to measuring chABC activity then a potentially more sensitive and accurate measurement of chABC would be available that could be used to give valuable insight into developing methods for delivery of chABC for treating CNS injury. Here we compare three assays used for chABC activity 65 measurements, demonstrating that WST-1 is a viable, sensitive and reliable alternative to the more classical methods for the measurement of chABC activity in model systems.
Results and Discussion
The three spectrophotometric assays tested included the use of 70 DMMB for the measurement of intact CSPGs present, the evolution of alkenes and in turn the absorbance signal at 232 nm produced from enzymatic activity and finally the novel WST-1 based assay. Initially the assays were compared for their sensitivity to changes in the concentration of chABC against a 75 fixed substrate concentration (chondroitin sulfate A, CS-A, 10 µM) and time of incubation (2 hours). Treatment of CS-A with a range of chABC concentrations resulted in contrasting results. It was clearly evident that the response for the WST-1 assay was of higher order with regards to linearity and response sensitivity in 80 comparison to both the 232 nm assay and the DMMB assay. This was indicated by the strongest linear correlation coefficient as well as the largest response to increases in enzyme concentration ( Figure 2 ). This linearity is presumably a result of the newly formed hemiacetal from the chABC reaction directly reducing the 85 WST-1 to its coloured formazan ( Figure 1 ). The steeper gradient suggests the range and sensitivity of the WST-1 assay was superior to the other two assays compared in this study. A more rigorous statistical analysis (Bonferroni-Dunn post-hoc 95 test (P ≤ 0.05)) was performed to determine at which concentration each assay could detect a significant difference from the background i.e. no enzyme present in the system. Using the WST-1 assay a significant difference could be detected at an enzyme concentration of 12.5 mU/ml, whilst detection using the 5 absorbance at 232 nm assay only was significantly different from background at 50 mU/ml. Surprisingly the DMMB assay showed no significant difference from background levels even at 200 mU/ml, despite an apparent trend in the data (Figure 2) . In an effort to confirm the reliability of the WST-1 assay 10 against a variety of enzyme concentrations, similar experiments were conducted at a range of chABC concentrations over increasing incubation times. The rate of product formation and in turn chABC catalysed CS-A cleavage was linear for concentration ranges between 5 -50 mU/ml chABC for up to 6 15 hours of digestion ( Figure 3 ). These results indicate that the assay is not substrate limiting or experiencing any feedback inhibition as a result of product accumulation within the system. Furthermore the direct relationship evident for all concentrations tested indicates, as expected, that the cleavage of CS-A is 20 proportional to the amount of chABC present in the system. With the lower limits of detection of enzyme activity against a fixed substrate concentration determined, we felt it was important to measure assay sensitivity with samples containing small amounts of substrate (CS-A). We incubated a range of low CS-A 30 concentrations (0.01 -0.5 µM) with a fixed concentration of chABC (50 mU/ml). The concentration of enzyme chosen was based on its ability to produce significant digestion after 2 hours of incubation when tested with the WST-1 assay, the absorbance at 232 nm assay and the DMMB assay. Once again the WST-1 35 based assay provided the best sensitivity ( Figure 4A ). Using the same statistical analysis as above we found that no values tested in either the DMMB assay or by measuring the absorbance of samples at 232 nm were significantly above baseline levels ( Figure 4B,C) . The WST-1 assay however showed significance at 40 all concentrations of substrate greater then 0.05 µM CS-A. Now that we had demonstrated the lower detection limits of the enzyme and substrate at fixed substrate and enzyme 50 concentrations respectively, we felt it was important to determine the usefulness of the WST-1 assay for assessing kinetic parameters of the enzyme. This is important from the perspective of using chABC as a therapeutic intervention against CNS injury as differences between enzyme batches and substrate preference 55 can be determined prior to use, as well as enzyme activity can be monitored in time course experiments. Due to its mode of action the WST-1 assay has the advantage that it can be used for the measurement of chABC kinetic parameters. Using this assay the substrate dependence of chABC activity was investigated and 60 found to conform to Michaelis-Menten kinetics ( Figure 5 ). The K m (8.01 ± 0.99 µM) determined using the WST-1 assay was within reasonable comparison to values determined by the absorbance at 232 nm method and those published within the literature (Table 1) . However the values for the k cat determined by the WST-1 assay (3123 ± 456 min -1 ) and by the absorbance at 232 nm (3848 75 ± 1339 min -1 ) method for the chABC sample used in this study was much lower then those published previously using the absorbance signal at 232 nm method (Table 1) . 22 The differences in k cat could be attributed to the fact that the previous study assessed a highly purified and freshly prepared chABC sample using the absorbance at 232 nm assay in comparison to the chABC used in this study. A limitation in the DMMB assay is that due to its method for determining activity of chABC it is unsuitable for the determination of kinetic parameters for the 5 enzyme and hence was not compared in these experiments. Although strong evidence of therapeutic benefit has been reported using chABC for treatment of CNS injury, questions 10 remain with regards to the persistence of enzyme activity at 37 °C. 7, 23 The disaccharide trehalose has long been shown to have a positive effect on enzyme stability in both resisting denaturation due to heat treatment as well as during the process of lyophilisation. 24, 25 Despite considerable debate with regards to the 15 mechanism by which trehalose is able to stabilise enzymes, [25] [26] [27] positive effects have been seen with this compound and chABC. Here we tested the ability of 1 M trehalose to stabilise chABC at 37 °C and improve persistence of activity, comparing each of 25 the assays for the ability to detect any loss in activity over time (Figure 6 ). It was evident that 1 M trehalose significantly preserved chABC activity at 37 °C, consistent with findings reported in the literature 23 and evident to varying degrees in each of the assays compared ( Figure 6 ). This was also confirmed by 30 SDS-PAGE using decorin as a substrate to directly show the degradation of sulfated GAG side chains from a core protein (Supporting Figures S1 and S2) . Once again the best sensitivity was seen with the WST-1 assay which showed significant stabilisation from day 5 onwards when comparing the trehalose 35 stabilised samples to the control chABC at the same time points. The measurement of alkene formation at 232 nm showed a similar result but with significant stabilisation only detected from day 10 onwards. Interestingly, using the DMMB assay resulted in similar trends but no conclusive significant differences were 40 observed between the trehalose stabilised samples and that of the control chABC samples, despite clear evidence from the SDS-PAGE experiments that demonstrate loss of chABC activity in the absence of trehalose (Supporting information S1, S2).
Conclusions
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The use of chABC has been demonstrated to be a potentially viable therapeutic option for degrading CSPGs at the site of a CNS injury. 6, 23, 28 As a result, useful biochemical assays need to be developed to measure the effectiveness of the enzyme in a variety of conditions. We have demonstrated that the water 50 soluble tetrazolium dye WST-1 is an effective reagent for the detection of reducing end sugars produced by chABC induced enzymatic cleavage of suitable biological substrates. In comparison to other spectrophotometric assays used for the measurement of chABC activity, the WST-1 based assay 55 provides superior results with regards to response and sensitivity at low levels of enzyme and substrate. This assay can also be used to measure the kinetic parameters of chABC as well as the direct thermal stabilisation of chABC in the presence of trehalose.
The WST-1 assay may be overall a more general strategy and 60 will find utility in the analyses of chABC activity for industrial and biotechnological purposes. 
WST-1 chABC assay
Assay conditions consisted of 90 µl substrate at the desired concentration (CS-A prepared in PBS pH 7.4, 0.01 µM -270 µM) with 10 µl chABC (5 mU/ml -200 mU/ml) added at t = 0.
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Samples were incubated for 2 hours at 37 °C before being quenched with 100 µl WST-1 working reagent (1.1 mg/ml WST-1 prepared in 0.1 M NaOH). Samples were then transferred to an incubator at 60 °C for 1 hour to allow for colour development before measuring the absorbance of the samples in a 96-well plate at 595 nm on an Enspire 2300 multimodal plate reader.
DMMB chABC assay
Assay conditions consisted of 90 µl substrate at desired concentration (CS-A prepared in PBS pH 7.4, 0.01 µM -270 5 µM) with 10 µl chABC (5 mU/ml -200 mU/ml) added at t = 0. Samples were incubated for 2 hours at 37 °C before 50 µl of reaction mixture was transferred to wells of a 96-well plate. To each well, 150 µl of DMMB working reagent was added (prepared according to previously described methods
14
) and the 10 absorbance at 525 nm was immediately measured within 15 seconds of the addition of working reagent.
Absorbance at 232 nm chABC assay
Assay conditions consisted of 90 µl substrate at desired concentration (CS-A prepared in PBS pH 7.4, 0.01 µM -270 15 µM) with 10 µl chABC (5 mU/ml -200 mU/ml) added at t = 0. Samples were incubated for 2 hours at 37 °C before being heat treated at 90 °C for 10 minutes to halt the reaction. Sample absorbance was then measured using a NanoDrop UV-Vis instrument set at 232 nm.
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Substrate inhibition experiment chABC at varying concentrations (10 µl at 5, 10, 25, 50 mU/ml), was combined with 90 µl of 20 µM CS-A at t = 0 hours. Samples were incubated at 37 °C for 0.5, 1, 2, 4 or 6 hours before being 25 quenched with WST-1 working reagent and assayed for activity as described above. All assays were performed in triplicate. Samples were heat treated at 37 °C for 0.5, 10, 15 or 20 days and then were immediately frozen (-40 °C). The samples were then thawed together on ice and assayed for activity following the three protocols described above. For analysis of activity against decorin, 10 µl aliquots of the enzyme samples were combined 50 with decorin (10 µl, 800 µg/ml, 8 µg) and incubated together at 37 °C, for 4 hours. After reaction the samples where prepared and separated on a 10% SDS-PAGE gel following standard protocols.
